0000000001092627

AUTHOR

Juan Meseguer

showing 2 related works from this author

Effectiveness of progestogens to improve perinatal outcome in twin pregnancies : an individual participant data meta-analysis

2015

Background In twin pregnancies, the rates of adverse perinatal outcome and subsequent long-term morbidity are substantial, and mainly result from preterm birth (PTB). Objectives To assess the effectiveness of progestogen treatment in the prevention of neonatal morbidity or PTB in twin pregnancies using individual participant data meta-analysis (IPDMA). Search strategy We searched international scientific databases, trial registration websites, and references of identified articles. Selection criteria Randomised clinical trials (RCTs) of 17–hydroxyprogesterone caproate (17Pc) or vaginally administered natural progesterone, compared with placebo or no treatment. Data collection and analysis I…

Cervical pessaryAdultmedicine.medical_specialtymedicine.medical_treatmentPerinatal DeathDiseasesCervix UteriInfant Newborn DiseasesEnterocolitis NecrotizingPregnancy17 alpha-Hydroxyprogesterone CaproatemedicineHydroxyprogesteronesHumansTwin PregnancyProgesteroneBronchopulmonary DysplasiaCerebral HemorrhagePregnancyRespiratory Distress SyndromeRespiratory Distress Syndrome NewbornProgestogenIntravaginalObstetricsbusiness.industryEnterocolitisInfant NewbornObstetrics and GynecologyInfantTwinmedicine.diseaseNewbornCervical Length MeasurementClinical trialAdministration IntravaginalTreatment OutcomePremature birthCervical Length MeasurementRelative riskAdministrationPregnancy TwinPremature BirthFemaleProgestinsbusinessNecrotizing
researchProduct

Progestogens to prevent preterm birth in twin pregnancies:an individual participant data meta-analysis of randomized trials

2012

Abstract Background Preterm birth is the principal factor contributing to adverse outcomes in multiple pregnancies. Randomized controlled trials of progestogens to prevent preterm birth in twin pregnancies have shown no clear benefits. However, individual studies have not had sufficient power to evaluate potential benefits in women at particular high risk of early delivery (for example, women with a previous preterm birth or short cervix) or to determine adverse effects for rare outcomes such as intrauterine death. Methods/design We propose an individual participant data meta-analysis of high quality randomized, double-blind, placebo-controlled trials of progestogen treatment in women with …

Adultmedicine.medical_specialtyReproductive medicine/dk/atira/pure/subjectarea/asjc/2700/2729lcsh:Gynecology and obstetricslaw.inventionStudy ProtocolClinical ProtocolsRandomized controlled trialPregnancylawObstetrics and GynaecologymedicineHumansAdverse effectTwin Pregnancylcsh:RG1-991Randomized Controlled Trials as TopicPregnancyModels StatisticalObstetricsbusiness.industryIndividual participant dataInfant NewbornPregnancy OutcomeObstetrics and Gynecologymedicine.diseasePregnancy ComplicationsPremature birthMeta-analysisPregnancy TwinPremature BirthFemaleProgestinsbusiness
researchProduct